Xiamen Amoytop Biotech Co., Ltd. (688278.SS)

Home
688278.SS
Financials

73.64 (CNY) • At close June 6, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3
Revenue Numbers are in millions	673.345	862.457	764.897	641.176	545.302	640.532	556.211	484.272	419.307	383.709	428.328	369.858	345.01	322.439	340.55	253.829	215.41	233.412	200.964	172.055	187.502	201.584	209.405	172.218	146.459	137.322	140.473
Cost of Revenue Numbers are in millions	45.965	53.58	50.962	44.397	37.765	46.436	29.795	26.091	37.732	47.266	47.091	38.289	36.593	46.998	31.933	23.744	22.459	18.994	22.292	19.329	23.034	19.587	20.842	22.009	17.535	15.062	18.302
Gross Profit Numbers are in millions	627.381	808.877	713.935	596.779	507.537	594.096	526.416	458.181	381.575	336.443	381.237	331.569	308.417	275.441	308.617	230.085	192.951	214.419	178.672	152.726	164.468	181.996	188.564	150.209	128.924	122.26	122.172
Gross Profit Ratio Numbers are in millions	0.932	0.938	0.933	0.931	0.931	0.928	0.946	0.946	0.91	0.877	0.89	0.896	0.894	0.854	0.906	0.906	0.896	0.919	0.889	0.888	0.877	0.903	0.9	0.872	0.88	0.89	0.87
Reseach & Development Expenses Numbers are in millions	66.749	101.365	79.431	68.89	43.576	87.114	65.651	39.498	37.712	48.828	49.1	31.56	20.347	24.654	18.23	21.439	17.184	31.807	11.201	18.291	15.376	14.64	11.586	13.008	14.171	12.672	11.184
General & Administrative Expenses Numbers are in millions	67.371	-113.412	154.817	-20.354	54.394	57.942	130.919	-20.49	41.938	-63.06	81.411	-13.051	28.015	-44.436	56.726	-9.042	19.633	-34.675	15.968	-10.152	21.971	-27.026	15.148	-6.408	14.698	-25.008	15.521
Selling & Marketing Expenses Numbers are in millions	279.058	-28.402	458.426	257.815	241.911	246.367	189.389	226.9	186.144	156.517	189.965	183.206	173.46	173.834	180.367	134.546	108.808	118.895	114.447	92.133	103.201	110.733	115.869	104.266	88.816	69.607	69.864
SG&A Numbers are in millions	346.429	-141.814	349.356	321.121	296.304	304.309	320.308	206.411	228.082	93.457	271.376	170.156	201.475	129.398	237.093	125.504	128.442	84.22	130.416	81.981	125.172	83.706	131.017	97.858	103.514	44.598	85.385
Other Expenses Numbers are in millions	-5.762	551.535	-2.557	-0.241	-13.148	-1,421.014	-11.032	-6.891	-0.604	102.024	-45.576	16.822	-0.029	-6.156	-9.945	-7.87	-8.803	-4.644	-3.605	-3.377	-7.447	-16.35	-6.073	-7.207	-6.407	-14.341	-4.229
Operating Expenses Numbers are in millions	407.416	511.086	426.231	390.253	339.341	1,421.014	317.41	307.776	265.19	244.31	274.901	218.538	221.793	220.378	227.144	174.664	145.166	164.726	140.788	121.508	129.606	135.037	142.475	128.829	116.465	93.66	95.367
Operating Income Numbers are in millions	219.965	297.791	287.704	206.526	170.516	-780.481	212.047	149.646	118.991	94.849	108.281	114.787	89.007	56.972	83.388	57.448	50.72	54.15	37.205	31.159	35.626	45.297	41.395	20.174	9.201	26.604	22.231
Operating Income Ratio Numbers are in millions	0.327	0.345	0.376	0.322	0.313	-1.218	0.381	0.309	0.284	0.247	0.253	0.31	0.258	0.177	0.245	0.226	0.235	0.232	0.185	0.181	0.19	0.225	0.198	0.117	0.063	0.194	0.158
Total Other Income Expenses Net Numbers are in millions	-10.749	-12.516	-7.549	1.703	-13.148	-7.054	-11.032	-6.891	-15.09	-6.017	-16.236	-12.3	-16.446	-6.625	-9.945	-7.87	-8.803	-4.644	-3.605	-3.377	-7.447	-9.307	-6.073	-3.267	-6.407	-8.852	-4.229
Income Before Tax Numbers are in millions	209.216	285.275	280.154	208.23	157.368	192.192	201.016	142.755	103.901	88.833	92.046	102.487	72.561	50.347	73.443	49.578	41.917	49.506	33.601	27.782	28.179	35.99	35.321	16.908	2.794	17.751	18.002
Income Before Tax Ratio Numbers are in millions	0.311	0.331	0.366	0.325	0.289	0.3	0.361	0.295	0.248	0.232	0.215	0.277	0.21	0.156	0.216	0.195	0.195	0.212	0.167	0.161	0.15	0.179	0.169	0.098	0.019	0.129	0.128
Income Tax Expense Numbers are in millions	27.087	11.822	30.347	32.695	28.56	6.44	34.288	24.75	19.728	2.218	25.295	26.285	15.108	-3.165	17.859	11.692	7.699	9.199	3.95	3.53	5.819	13.78	8.784	1.903	2.251	2.226	1.538
Net Income Numbers are in millions	182.129	273.453	249.807	175.534	128.808	186.543	166.728	118.006	84.173	86.615	66.751	76.202	57.452	53.513	55.584	37.887	34.218	40.307	29.651	24.252	22.36	22.209	26.537	15.005	0.542	15.526	16.464
Net Income Ratio Numbers are in millions	0.27	0.317	0.327	0.274	0.236	0.291	0.3	0.244	0.201	0.226	0.156	0.206	0.167	0.166	0.163	0.149	0.159	0.173	0.148	0.141	0.119	0.11	0.127	0.087	0.004	0.113	0.117
EPS Numbers are in millions	0.45	0.67	0.61	0.43	0.32	0.46	0.41	0.29	0.21	0.21	0.16	0.19	0.14	0.13	0.13	0.089	0.08	0.094	0.073	0.065	0.06	0.059	0.074	0.055	0.002	0.047	0.05
EPS Diluted Numbers are in millions	0.45	0.67	0.61	0.43	0.32	0.46	0.41	0.29	0.21	0.21	0.16	0.19	0.14	0.13	0.13	0.089	0.08	0.094	0.073	0.065	0.06	0.059	0.074	0.055	0.002	0.047	0.05
EBITDA Numbers are in millions	209.334	285.37	280.282	230.305	179.442	212.595	224.796	157.519	118.65	101.924	105.158	114.87	84.97	62.616	85.307	60.194	58.126	59.972	43.85	39.915	38.455	49.109	46.732	27.272	13.202	32.032	21.033
EBITDA Ratio Numbers are in millions	0.311	0.331	0.366	0.359	0.329	0.332	0.404	0.325	0.283	0.266	0.246	0.311	0.246	0.194	0.25	0.237	0.27	0.257	0.218	0.232	0.205	0.244	0.223	0.158	0.09	0.233	0.15

Xiamen Amoytop Biotech Co., Ltd.

SSE:688278.SS Add to watchlist

SSE:688278.SS